T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches

T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell hematologic neoplasm with a very poor prognosis and limited treatment options to date. Single-agent alemtuzumab remains the first line of therapy for the treatment-naive and relapsed/refractory patients. Prospective clinical trials are d...

Descripción completa

Detalles Bibliográficos
Autores principales: Colon Ramos, Ana, Tarekegn, Kidist, Aujla, Amandeep, Garcia de de Jesus, Katherine, Gupta, Sachin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948687/
https://www.ncbi.nlm.nih.gov/pubmed/33728186
http://dx.doi.org/10.7759/cureus.13237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948687/
https://www.ncbi.nlm.nih.gov/pubmed/33728186
http://dx.doi.org/10.7759/cureus.13237

Ejemplares similares